Sharpless employment status is unknown, but in previous transitions NCI directors have stayed on – The Cancer Letter

publication date: Jan. 22, 2021By Paul GoldbergOn Jan. 20, as required, Ned Sharpless submitted his resignation letter to the outgoing administration. Other Trump appointees did the same. At this writing, nothing has been said, but Ned Sharpless was at work on Thursday. It’s not publicly known whether Sharpless will be staying in the short term or the long term in the Biden administration, which…

Read the full article here

Source: cancerletter.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tags: cancer

Tweets with this article

The Cancer Letter

It’s not publicly known whether @NCIDirector Ned Sharpless will be staying in the short term or the long term in the @JoeBiden administration, which has focused on #cancer research with unprecedented understanding of the subject. https://t.co/7zBePtWUM0 https://t.co/85y4SDEdjr

Related Articles

Edward Copeland, surgeon and breast cancer expert, dies at 86 – The Cancer Letter

A renowned surgeon and international authority on breast cancer, American College of Surgeons Past-President Edward (Ted) M. Copeland III, died on March 31 at the…

The Cancer Letter April 15, 2024

FDA grants accelerated approval to Enhertu for unresectable or metastatic HER2-positive solid tumors – The Cancer Letter

FDA granted accelerated approval to Enhertu (fam-trastuzumab deruxtecan-nxki) for adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment…

The Cancer Letter April 15, 2024

Association of Cancer Center Administrators holds inaugural meeting in Philadelphia – The Cancer Letter

Sporting a leprechaun’s hat and a giant green bowtie, Matthew Huesser, DBA, conference chairperson and vice president for cancer research administration at the Sidney Kimmel…

The Cancer Letter April 15, 2024

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients – The Cancer Letter

Researchers at MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer radiation before mastectomy allowed for concurrent breast reconstruction…

The Cancer Letter April 15, 2024

NCI creates Cancer Equity Leaders group to improve cancer health equity – The Cancer Letter

To address inequities in cancer health, NCI is collaborating with a diverse team of experts and cancer center directors—named the Cancer Equity Leaders (CEL)—to learn…

The Cancer Letter April 15, 2024

Edward M. Copeland III: “My lifestyle was practicing surgery” – The Cancer Letter

In 2013, the American College of Surgeons conducted an oral history interview with former ACS president Edward M. Copeland III. Copeland spoke with archivist Jane…

The Cancer Letter April 15, 2024

Julie Bauman, Stephanie Blank to lead NRG Oncology Cancer Prevention & Control Committee – The Cancer Letter

Julie Bauman and Stephanie V. Blank were named chair and vice chair, respectively, of the NRG Oncology Cancer Prevention & Control Committee. To access this…

The Cancer Letter April 15, 2024

Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials – The Cancer Letter

An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer…

The Cancer Letter April 15, 2024

Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials – The Cancer Letter

An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer…

The Cancer Letter April 12, 2024

Rathmell: To improve funding outlook, we must reverse distrust in science – The Cancer Letter

With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional…

The Cancer Letter April 12, 2024